-- 石油输出国组织(欧佩克)周一下调了第二季度石油需求预测,原因是中东冲突,但由于预期下半年需求将反弹,因此维持了全年预测不变。 欧佩克在其最新的月度市场报告中表示,预计未来三个月全球石油日均消费量为1.051亿桶。上个月,该组织预测第二季度需求量为1.056亿桶。 欧佩克表示,此次下调反映了经合组织和非经合组织成员国的预期均有所降低,“主要原因是鉴于中东局势持续发展,石油需求增长出现轻微的暂时性疲软”。“然而,预计下半年这种疲软将得到弥补。” 第一季度全球石油日均消费量为1.057亿桶。 美国军方原定于美国东部时间周一上午10点开始封锁进出伊朗港口的海上交通。此前,美国和伊朗代表团周末在巴基斯坦举行的谈判未能达成协议,加剧了人们对双方本已脆弱的停火协议能否持久的担忧。 该组织继续预测,2026年全球石油消费量将增加138万桶/日,明年将增加134万桶/日。 欧佩克维持其对2026年全球经济增长的预期,为3.1%,其中美国经济增长率为2.2%。欧佩克仍然预计明年全球经济增长率为3.2%,美国经济增长率为2%。 欧佩克预计,在消费支出的推动下,美国经济今年将保持“稳健增长势头”,但短期内的通胀动态需要“密切关注”。该组织预计,美联储将在上半年维持利率不变,并可能在下半年逐步放松货币政策,“可能降息一到两次”。 周五公布的政府数据显示,受中东冲突导致能源价格大幅上涨的影响,美国3月份消费者通胀率飙升至近四年来的最高月度水平。 石油输出国组织(欧佩克)维持其此前预测,即今年未参与《合作宣言》(DoC)的产油国的液体燃料日产量将增加63万桶。《合作宣言》是欧佩克+的名称,该组织由欧佩克成员国及其非欧佩克盟友组成。液体燃料产量包括原油、凝析油和天然气凝析液。 午盘交易中,西德克萨斯中质原油价格上涨6.1%,至每桶102.48美元;布伦特原油价格上涨6.8%,至每桶101.67美元。
Related Articles
Research Alert: CFRA Keeps Buy Opinion On Shares Of The Hartford Insurance Group, Inc.
CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We trim our 12-month target price by $8 to $155, valuing HIG shares at 11.3x our 2026 operating EPS estimate of $13.75 (cut by $0.45) and at 10.6x our 2027 EPS estimate of $14.65 (cut by $0.30), vs. the shares' one-year average forward multiple of 10.3x and peer average of 13x. Q1 EPS of $3.09 vs. $2.20 a year ago missed our $3.60 estimate and $3.39 consensus view. Operating revenue growth of 6.2% was in line with our 6%-10% forecast, amid 5.3% earned premium growth, 13% higher net investment income, and 7.9% fee revenue growth. Q1 written premium growth of 4% and full-year 2025 growth of 7% bode well for 2026 revenue trends as premiums are earned. Underwriting results improved significantly, with Personal Lines combined ratio improving to 87.7% from 106.1% and underlying combined ratio to 85.0% from 89.7%. Business Insurance combined ratio was stable at 94.8%. Weighing the Q1 EPS miss with HIG's decent top-line growth and discounted valuation to peers, we view the shares as undervalued.
Research Alert: CFRA Keeps Strong Buy Opinion On Shares Of Baker Hughes
CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We raise our 12-month target price by $14 to $82, reflecting a combination of our sum-of-the-parts (SOTP) and DCF models. For our SOTP model, we presume the oilfield services business (about 50% of BKR's franchise) to be valued at about 10x projected 2027 EBITDA (in line with major peers) and its industrial energy technology business (the other 50%) valued at 14x projected 2027 EBITDA (in line with the peer median). This blended approach, yielding a 12x multiple, implies a value of $73 per share. Meanwhile, our DCF model, using medium-term free cash flow growth of 5% per year, terminal growth of 2.5%, discounted at a WACC of 6.3%, yields intrinsic value of $91 per share. We cut our 2026 EPS estimate by $0.47 to $2.48, but we raise 2027's by $0.07 to $3.24. We acknowledge that the oilfield services business is likely to struggle in 2026 owing to the U.S.-Iran conflict, but the IET business appears quite robust and likely to be a source of both accelerating revenue growth and margins.
Research Alert: CFRA Maintains Hold Opinion In Shares Of Wab
CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We lift our 12-month target to $285 from $275 following WAB's Q1 earnings print, valuing shares at 24.2x our 2027 EPS outlook of $11.76 (revised from $11.46; 2026 EPS estimate up to $10.57 from $10.50), a slight premium to WAB's long-term historical multiple average given structural improvements in earnings quality. While we are cautious on signs of overcapacity in the freight market, an elevated order backlog (12-month sits at over $9 billion), internal initiatives to shore up margins, and potential synergies from M&A activity positions WAB to continue growing earnings at double-digit rates in 2026-2027, in our view. Despite tariff-related cost pressures, WAB has done a commendable job of defending margins via a mix of pricing, lean manufacturing, and pruning of lower-profit operations. Q1 results were mixed but overall positive, in our view. We maintain our Hold recommendation on shares.